Agreed. I think the short term outlook looks a little concerning though. Unless specialty grows even more rapidly than it has (and with Tolsura this is a possibility). Looks like key generic brands will lose share with competition - the main offset we've been waiting for is Nuvaring which is now more than 12 months away. I'm a huge believer in the long term of this company. But I don't see the price doing much in the short term. Hope I am wrong, as I was well wrong with my previous predictions too! Good luck to all holders.
Agreed. I think the short term outlook looks a little concerning...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $5.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 1000 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |